Home|Journals|Articles by Year|Audio Abstracts
 

Review Article

AAM. 2023; 12(4): 398-403


Emerging Potentials of Oral Gold Therapeutics (Swarna Prashana ) For Pediatric Age in Post COVID Era

Piyush Verma, Ashutosh Kumar Pathak.




Abstract

Objective- To review the potential benefits of Swarna / Swarnaprashana (a kind of gold therapeutics) in pediatric age for infectious diseases.
Data Source- various published researches has been reviewed.
Review Methods- qualitative analysis of the themes of the researches done previously was done and potential benefits and future prospects and idea was generated.
Results- Swarna (gold) nanoparticles has proven virucidal effect.
Conclusion- The use of Swarna in Indian system of medicine is from very ancient times. This sacred element had very broad use since it was incorporated in human civilizations. Today we are facing the covid-19 pandemic with such a disastrous effect on public health. This era has shown the mankind that whatever be the understanding and developments of modern medical system for infectious diseases, the microbe world is always a step ahead of us and modifying itself. The ancient use of Swarna as swarnaprashana in children has better chances of improving the immunity and fighting certain viral infections.

Key words: Keywords- Swarnaprashana, Swarna bhasma, Gold nanoparticles






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.